BWP
DGX icon

Balboa Wealth Partners’s Quest Diagnostics DGX Stock Holding History

Balboa Wealth Partners’s Portfolio DGX Stock Details DGX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-2,032
Closed -$287K – 307
2023
Q1 		$287K Buy
2,032
+744
+58% +$106K 0.11% 163
2022
Q4 		$201K Buy
+1,288
New +$185K 0.09% 212

Other funds holding DGX

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $178B AUM 37.23% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Balboa Wealth Partners's DGX Position: Q2 2023 in Review

Balboa Wealth Partners sold out of Quest Diagnostics (DGX) in Q2 2023, closing a stake of 2,032 shares — an estimated $287K sold.

Balboa Wealth Partners first reported a position in DGX in Q4 2022 and held it in 2 quarters. The position peaked at $287K in Q1 2023. 818 funds tracked by Wall St. Rank hold DGX as of Q2 2023.

  • Balboa Wealth Partners reported no remaining Quest Diagnostics position as of Q2 2023 after selling out during the quarter.
  • Balboa Wealth Partners sold 2,032 Quest Diagnostics shares in Q2 2023, an estimated $287K.
  • Balboa Wealth Partners first reported a position in Quest Diagnostics in Q4 2022 and held it in 2 quarters.
  • Balboa Wealth Partners's Quest Diagnostics position peaked at $287K in Q1 2023.
  • 818 funds tracked by Wall St. Rank held Quest Diagnostics as of Q2 2023.

Based on Balboa Wealth Partners's 13F filing for Q2 2023, filed 8 Aug 2023.